
ProMed Pharma Secures DEA Registration for Schedule III Controlled Substances
Milestone Expands Company’s Capabilities in Controlled Drug Development and Manufacturing PLYMOUTH, MN, UNITED STATES, May 27, 2025 /EINPresswire.com/ -- ProMed Pharma, a leading provider of polymer-based drug delivery solutions and contract …